Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (2693)	1/26/2001 12:07:15 PM
From: Ian@SI	Respond to of 52153

Rather than trying to take money off the table as the stock goes up, I tend to sell PUTs after the stock has gone down. Worst case, I get to own more shares of a company I'd like to own at a lower cost basis than I believed possible at the time I sold the PUTs. Best case I just keep the premium and sell some more PUTs. With ALXN, I've taken well over double my initial investment in shares, so I'm overdue to take an assignment. Re death endpoint statistically non-significant: Tell Al Waxman that. Seriously, there are so many overpriced stocks without ALXN's prospects. I fail to understand why someone would take unnecessary risk by shorting ALXN. Best Ian